Last Price Today's Change   Day's Range   Trading Volume
163.73   -0.66 (0.40%)  163.50 - 166.39  375,893


Avg Volume (4 weeks):879,933
4 Weeks Range:156.48 - 167.66
4 Weeks Price Volatility (%):
52 Weeks Range:119.01 - 167.66
52 Weeks Price Volatility (%):
Average Price Target: 88.00
Price Target Upside/Downside: -75.73


No recent Headlines for this stock.

Business Background

CSL Limited is a biotherapeutics company that develops and delivers biotherapies. The Company's principal activities are research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. Its segments include CSL Behring, Seqirus and CSL Intellectual Property. The CSL Behring segment manufactures, markets and develops plasma therapies (plasma products and recombinants). The Seqirus segment manufactures and distributes non-plasma biotherapeutic products. Seqirus manufactures, sells and distributes a range of vaccines, antivenoms and other pharmaceutical products in Australia and New Zealand. It also manufactures and markets in vitro diagnostic products through Seqirus immunohematology. The CSL Intellectual Property segment is engaged in licensing of intellectual property generated by the Company to unrelated third parties. The Company has facilities in Australia, Germany, Switzerland, the United Kingdom and the United States.

  Be the first to like this.


589  680  697  9191 

Top 10 Active Counters
 WFE 0.013-0.002 
 AGO 0.026+0.002 
 GLA 0.008+0.002 
 AYR 0.010.00 
 KRC 0.165+0.01 
 ASN 0.049-0.01 
 IMU 0.0340.00 
 BLK 0.083+0.001 
 RRS 0.005+0.002 
 VXR 0.0150.00 
Partners & Brokers